René Fiasse

Inflammatory Bowel Disease A Positive Response to Infliximab in Crohn Disease: Association with a Higher Systemic Inflammation Before Treatment But Not With -308 TNF Gene Polymorphism

Édouard Louis, Séverine Vermeire, P. Rutgeerts et al. · Scandinavian Journal of Gastroenterology · 2002 · 242 citations · Full text

Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease

Séverine Vermeire, Édouard Louis, An Carbonez et al. · The American Journal of Gastroenterology · 2002 · 224 citations · Full text

Inflammatory Bowel Disease A Positive Response to Infliximab in Crohn Disease: Association with a Higher Systemic Inflammation Before Treatment But Not With -308 TNF Gene Polymorphism

Édouard Louis, Séverine Vermeire, P. Rutgeerts et al. · Scandinavian Journal of Gastroenterology · 2002 · 223 citations

Chronic Inflammatory Diseases, Higher Systemic Inflammation, Immunology +23

Efficacy and Safety of Prolonged-Release Lanreotide in Patients With Gastrointestinal Neuroendocrine Tumors and Hormone-Related Symptoms

A.N.M. Wymenga, Barbro Eriksson, Pasi Salmela et al. · Journal of Clinical Oncology · 1999 · 223 citations

NOD2/CARD15 does not influence response to infliximab in Crohn's disease

Séverine Vermeire, Édouard Louis, Paul Rutgeerts et al. · Gastroenterology · 2002 · 207 citations · Full text

Inflammation, Anti-inflammatory, Autoimmune Disease +7